Another lethal risk of the “little purple pill”—exposed

I know I urge you regularly to stay away from heartburn drugs like your life depends on it. (Because let’s be very clear here—it does.)

But you better believe I’ll continue to shout it from the rooftops every time I come across a new report detailing the outrageous risks of these supposedly “safe” medications. And it just so happens that yet another study is making the rounds…

Antacids rocket diabetes risk

A team of Chinese researchers looked at data from three different studies—the Nurses’ Health Study, the Nurses’ Health Study II, and the Health Professionals Follow-Up Study—featuring a total of nearly 205,000 people.

This data included details of subjects’ medical history, health, and lifestyle—including whether or not they used proton pump inhibitors (PPIs), a common class of heartburn drugs, including the notorious “little purple pill”—twice a week or more.

None of the subjects were diabetic at the start of the study. But even after accounting for a host of variables associated with diabetes—including weight, high blood pressure, high cholesterol, and a sedentary lifestyle—people who took PPIs regularly were nearly 25 percent more likely to develop the disease over the next ten years.

Plus, the danger seemed to increase with the length of use. In other words, people who only took the drugs for two years were five percent more likely to develop diabetes… and the risk only increased from there. (Surprisingly, it was actually higher in people with normal blood pressure and lower weight.)

To make matters worse, it wasn’t just PPIs that caused problems here. The researchers also identified a 14 percent higher risk of diabetes in people taking H2 receptor blockers—a different class of heartburn drugs.

But the good news? People who stopped taking heartburn drugs saw their risk of developing diabetes drop—and it continued to decline the longer they stayed off of them.

Trash your antacids today     

Now, I will admit that this is an observational study, which means it can’t prove that heartburn drugs cause diabetes. At this point, it’s still just an association.

But given the horrifying laundry list of problems linked to heartburn drugs—from bone loss to cancer to dementia—is it really worth the risk? Especially given the way long-term antacid use can negatively impact your microbiome, which has a hand in just about every facet of your health imaginable.

(Learn more about these risks in the May 2020 issue of my monthly newsletter, Logical Health Alternatives [“WARNING: Heartburn drugs come with more risks than benefits”]. If you’re not yet a subscriber, become one today!)

The bottom line is that if you don’t need antacid drugs, you absolutely should NOT be taking them. And guess what? Most people don’t actually NEED them.

Antacids have always been one of my most hated drugs. And that’s partly because most cases of heartburn have absolutely nothing to do with excessive stomach acid.

The real culprits come down to issues like the food you eat, the weight pushing on your diaphragm, and even too little stomach acid (a common problem that gets worse with age). So, at the end of the day, a PPI prescription is only going to make most of these problems worse, not better.

But there’s one more reason why you should make ditching antacids a top priority, starting today… and it’s one we haven’t talked about here before. I’ll tell you all about it tomorrow. So, as always, stay tuned…

P.S. Join me this Sunday, October 25^th at 3PM-EDT as I reveal details on dozens of simple, natural solutions that can help you fight the devastating effects of heart disease. But hurry! Space to this exclusive, FREE event is limited. Click here now to reserve your spot to my Ultimate Heart Summit—before it’s too late.

Source:

“Common Heartburn Meds Tied to Higher Diabetes Risk.” HealthDay News, 10/02/2020. (consumer.healthday.com/gastrointestinal-information-15/heartburn-gerd-and-indigestion-news-369/common-heartburn-meds-tied-to-higher-diabetes-risk-761852.html)